Papers - MATSUKI Kota
-
Cerebrotendinous Xanthomatosis: Molecular Pathogenesis, Clinical Spectrum, Diagnosis, and Disease-Modifying Treatments
Koyama Shingo, Sekijima Yoshiki, Ogura Masatsune, Hori Mika, Matsuki Kota, Miida Takashi, Harada-Shiba Mariko
Journal of Atherosclerosis and Thrombosis 28 ( 9 ) 905 - 925 2021.9
-
Current Diagnosis and Management of Primary Chylomicronemia
Okazaki Hiroaki, Gotoda Takanari, Ogura Masatsune, Ishibashi Shun, Inagaki Kyoko, Daida Hiroyuki, Hayashi Toshio, Hori Mika, Masuda Daisaku, Matsuki Kota, Yokoyama Shinji, Harada-Shiba Mariko
Journal of Atherosclerosis and Thrombosis 28 ( 9 ) 883 - 904 2021.9
-
Current Diagnosis and Management of Tangier Disease
Koseki Masahiro, Yamashita Shizuya, Ogura Masatsune, Ishigaki Yasushi, Ono Koh, Tsukamoto Kazuhisa, Hori Mika, Matsuki Kota, Yokoyama Shinji, Harada-Shiba Mariko
Journal of Atherosclerosis and Thrombosis 28 ( 8 ) 802 - 810 2021.8
-
Diagnosis and Management of Sitosterolemia 2021
Tada Hayato, Nomura Akihiro, Ogura Masatsune, Ikewaki Katsunori, Ishigaki Yasushi, Inagaki Kyoko, Tsukamoto Kazuhisa, Dobashi Kazushige, Nakamura Kimitoshi, Hori Mika, Matsuki Kota, Yamashita Shizuya, Yokoyama Shinji, Kawashiri Masa-aki, Harada-Shiba Mariko
Journal of Atherosclerosis and Thrombosis 28 ( 8 ) 791 - 801 2021.8
-
Homozygous Familial Hypercholesterolemia
Nohara Atsushi, Tada Hayato, Ogura Masatsune, Okazaki Sachiko, Ono Koh, Shimano Hitoshi, Daida Hiroyuki, Dobashi Kazushige, Hayashi Toshio, Hori Mika, Matsuki Kota, Minamino Tetsuo, Yokoyama Shinji, Harada-Shiba Mariko
Journal of Atherosclerosis and Thrombosis 28 ( 7 ) 665 - 678 2021.7
-
Current Status of Familial LCAT Deficiency in Japan
Kuroda Masayuki, Bujo Hideaki, Yokote Koutaro, Murano Takeyoshi, Yamaguchi Takashi, Ogura Masatsune, Ikewaki Katsunori, Koseki Masahiro, Takeuchi Yasuo, Nakatsuka Atsuko, Hori Mika, Matsuki Kota, Miida Takashi, Yokoyama Shinji, Wada Jun, Harada-Shiba Mariko
Journal of Atherosclerosis and Thrombosis 28 ( 7 ) 679 - 691 2021.7
-
Evinacumab for Homozygous Familial Hypercholesterolemia.
Raal FJ, Rosenson RS, Reeskamp LF, Hovingh GK, Kastelein JJP, Rubba P, Ali S, Banerjee P, Chan KC, Gipe DA, Khilla N, Pordy R, Weinreich DM, Yancopoulos GD, Zhang Y, Gaudet D; ELIPSE HoFH Investigators.
The New England Journal of Medicine 383 ( 8 ) 711 - 720 2020.8
-
Familial Hypercholesterolemia and Lipoprotein Apheresis
Makino Hisashi, Koezuka Ryo, Tamanaha Tamiko, Ogura Masatsune, Matsuki Kota, Hosoda Kiminori, Harada-Shiba Mariko
Journal of Atherosclerosis and Thrombosis 26 ( 8 ) 679 - 687 2019.8
-
Dominance of the hypothalamus-pituitary-adrenal axis over the renin-angiotensin-aldosterone system is a risk factor for decreased insulin secretion.
Makoto Daimon, Aya Kamba, Hiroshi Murakami, Satoru Mizushiri, Sho Osonoi, Kota Matsuki, Eri Sato, Jutaro Tanabe, Shinobu Takayasu, Yuki Matsuhashi, Miyuki Yanagimachi, Ken Terui, Kazunori Kageyama, Itoyo Tokuda, Shizuka Kurauchi, Shigeyuki Nakaji
Scientific reports 7 ( 1 ) 11360 - 11360 2017.9
-
Association between serum prolactin levels and insulin resistance in non-diabetic men.
Makoto Daimon, Aya Kamba, Hiroshi Murakami, Satoru Mizushiri, Sho Osonoi, Masato Yamaichi, Kota Matsuki, Eri Sato, Jutaro Tanabe, Shinobu Takayasu, Yuki Matsuhashi, Miyuki Yanagimachi, Ken Terui, Kazunori Kageyama, Itoyo Tokuda, Ippei Takahashi, Shigeyuki Nakaji
PloS one 12 ( 4 ) e0175204 2017.4
-
Association between Higher Serum Cortisol Levels and Decreased Insulin Secretion in a General Population.
Aya Kamba, Makoto Daimon, Hiroshi Murakami, Hideyuki Otaka, Kota Matsuki, Eri Sato, Jutaro Tanabe, Shinobu Takayasu, Yuki Matsuhashi, Miyuki Yanagimachi, Ken Terui, Kazunori Kageyama, Itoyo Tokuda, Ippei Takahashi, Shigeyuki Nakaji
PloS one 11 ( 11 ) e0166077 - e0166077 2016.11
-
Clinical Significance of Determining Plasma MicroRNA33b in Type 2 Diabetic Patients with Dyslipidemia.
Yuki Kimura, Naoki Tamasawa, Koki Matsumura, Hiroshi Murakami, Maki Yamashita, Kota Matsuki, Jutaro Tanabe, Hiroshi Murakami, Jun Matsui, Makoto Daimon
Journal of atherosclerosis and thrombosis 23 ( 11 ) 1276 - 1285 2016.11
-
Transforming growth factor beta1 and aldosterone.
Matsuki K, Hathaway CK, Chang AS, Smithies O, Kakoki M.
Current Opinion in Nephrology and Hypertension 24 ( 2 ) 139 - 144 2015.3
-
Identification of aortic arch-specific quantitative trait loci for atherosclerosis by an intercross of DBA/2J and 129S6 apolipoprotein E-deficient mice.
Yukako Kayashima, Natalia A Makhanova, Kota Matsuki, Hirofumi Tomita, Brian J Bennett, Nobuyo Maeda
PloS one 10 ( 2 ) e0117478 - e0117478 2015.2
-
Isolated low-HDL cholesterol in Japanese patients with type 2 diabetes.
Matsumura K, Kimura Y, Murakami H, Yamashita M, Matsuki K, Tanabe J, Murakami H, Matsui J, Tamasawa N, Daimon M
Diabetology International 6 ( 4 ) 290 - 299 2015.1
-
The role of transforming growth factor β1 in the regulation of blood pressure.
Matsuki K, Hathaway CK, Lawrence MG, Smithies O, Kakoki M.
Current Hypertension Reviews 10 ( 4 ) 223 - 238 2014
-
Primary aldosteronism and impaired natriuresis in mice underexpressing TGFβ1.
Masao Kakoki, Oleh M Pochynyuk, Catherine M Hathaway, Hirofumi Tomita, John R Hagaman, Hyung-Suk Kim, Oleg L Zaika, Mykola Mamenko, Yukako Kayashima, Kota Matsuki, Sylvia Hiller, Feng Li, Longquan Xu, Ruriko Grant, Alejandro M Bertorello, Oliver Smithies
Proceedings of the National Academy of Sciences of the United States of America 110 ( 14 ) 5600 - 5605 2013.4
-
Reduction of paraoxonase-1 activity may contribute the qualitative impairment of HDL particles in patients with type 2 diabetes.
Hiroshi Murakami, Jutaro Tanabe, Naoki Tamasawa, Koki Matsumura, Maki Yamashita, Kota Matsuki, Hiroshi Murakami, Jun Matsui, Toshihiro Suda
Diabetes research and clinical practice 99 ( 1 ) 30 - 38 2013.1
-
Reduced cellular cholesterol efflux and low plasma high-density lipoprotein cholesterol in a patient with type B Niemann-Pick disease because of a novel SMPD-1 mutation.
Tamasawa N, Takayasu S, Murakami H, Yamashita M, Matsuki K, Tanabe J, Murakami H, Matsui J, Satoh K, Suda T
Journal of clinical lipidology 6 ( 1 ) 74 - 80 2012.1
-
Insulin suppresses HDL-mediated cholesterol efflux from macrophages through inhibition of neutral cholesteryl ester hydrolase and ATP-binding cassette transporter G1 expressions.
Maki Yamashita, Naoki Tamasawa, Kota Matsuki, Jutaro Tanabe, Hiroshi Murakami, Jun Matsui, Toshihiro Suda
Journal of atherosclerosis and thrombosis 17 ( 11 ) 1183 - 1189 2010.8